These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 40389)

  • 21. [Pharmacological properties of dl-2-(3'-t-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl) thiazole hydrochloride (S-596), a new beta-adrenergic blocking agent (author's transl)].
    Hara Y; Sato E; Miyagishi A; Aono S; Nakatani H
    Nihon Yakurigaku Zasshi; 1979 Oct; 75(7):707-20. PubMed ID: 94296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative investigation of the effects of metoprolol, propranolol, practolol, and verapamil in the acute phase of experimental myocardial infarction.
    Bernauer W
    Klin Wochenschr; 1982 Jan; 60(2):87-96. PubMed ID: 6121935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Modification of ouabain-induced arrhythmia test in anesthesized guinea pigs].
    Luca C; Sardi B; Valli L; Pacei E
    Cardiologia; 1987 Jan; 32(1):85-8. PubMed ID: 3107817
    [No Abstract]   [Full Text] [Related]  

  • 24. A comparison of the anti-arrhythmic actions of I.C.I. 50172 and (--)-propranolol and their effects on intracellular cardiac action potentials and other features of cardiac function.
    Papp JG; Williams EM
    Br J Pharmacol; 1969 Oct; 37(2):391-9. PubMed ID: 4390670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The reversal of experimental cardiac arrhythmias by indoramin (Wy 21901).
    Alps BJ; Hill M; Fidler K; Johnson ES; Wilson AB
    J Pharm Pharmacol; 1971 Sep; 23(9):678-86. PubMed ID: 4398246
    [No Abstract]   [Full Text] [Related]  

  • 26. The function of newer antiarrhythmic drugs under special consideration of beta blocking adrenergic agents.
    Shalsha KG
    Proc Rudolf Virchow Med Soc City N Y; 1968-1969; 27():201-11. PubMed ID: 4402617
    [No Abstract]   [Full Text] [Related]  

  • 27. beta-Blockers and myocardial infarction.
    Moser M; Gorlin R
    Arch Intern Med; 1982 Sep; 142(9):1618-9. PubMed ID: 6126165
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhibition of Na+/Ca2+ overload with R 56,865 protects against cardiac arrhythmias elicited by ouabain in vivo in guinea-pigs.
    Lu HR; Remeysen P; De Clerck F
    Eur J Pharmacol; 1993 Apr; 235(1):89-93. PubMed ID: 8519283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Observations on models used for the evaluation of antiarrhythmic drugs.
    Baum T; Eckfeld DK; Shropshire AT; Rowles G; Varner LL
    Arch Int Pharmacodyn Ther; 1971 Sep; 193(1):149-70. PubMed ID: 5111320
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacologic properties of acebutolol: relationship of hydrophilicity to central nervous system penetration.
    Abernethy DR; Arendt RM; Greenblatt DJ
    Am Heart J; 1985 May; 109(5 Pt 2):1120-5. PubMed ID: 2859774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiarrhythmic effects of dichloroisoprenaline, H 56-28, ICI 50172, LB 46, MJ 1999 and propranolol on aconitine-induced atrial and ouabain-induced ventricular arrhythmias.
    Hashimoto K; Nakayama K; Oshima T; Kumakura S
    Experientia; 1971 Jun; 27(6):666-7. PubMed ID: 4397569
    [No Abstract]   [Full Text] [Related]  

  • 32. The antiarrhythmic effect of prostaglandin E2 on catecholamine-induced arrhythmias.
    Mest HJ; Winkler J; Förster W
    Acta Biol Med Ger; 1977; 36(7-8):1193-6. PubMed ID: 612098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of tiprenolol, practolol and propranolol on experimental ventricular tachyarrhythmias.
    Allen JD; Shanks RG
    Br J Pharmacol; 1974 Jun; 51(2):179-85. PubMed ID: 4155971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of lorcainide, a new antiarrhythmic agent, on experimental cardiac arrhythmias].
    Fukuda H; Goto M; Kondo M; Uchigasaki T; Sekino Y
    Nihon Yakurigaku Zasshi; 1983 Feb; 81(2):115-26. PubMed ID: 6852683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of the effects of bretylium, lignocaine and propranolol on experimental cardiac arrhythmias.
    Allen JD; Shanks RG; Zaidi SA
    Br J Pharmacol; 1969 Oct; 37(2):526P-527P. PubMed ID: 5348446
    [No Abstract]   [Full Text] [Related]  

  • 36. Cardiovascular and antiarrhythmic effects of 1-(4,5-dichloro-2-thienyl)-2-t-butylaminoethanol (QM-5119), a new beta-adrenergic blocking agent.
    Darias V; del Río J
    Arzneimittelforschung; 1974 Nov; 24(11):1756-9. PubMed ID: 4155633
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of Na+/Ca2+ exchange inhibitor, KB-R7943 on ouabain-induced arrhythmias in guinea-pigs.
    Watano T; Harada Y; Harada K; Nishimura N
    Br J Pharmacol; 1999 Aug; 127(8):1846-50. PubMed ID: 10482915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular and beta-adrenergic blocking effects of timolol.
    Mouillé P; Schmitt H; Cheymol G; Gauter E
    Eur J Pharmacol; 1976 Feb; 35(2):235-43. PubMed ID: 2481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental evaluation of antiarrhythmic drugs in the guinea pig.
    Giudicelli JF; Witchitz S; Larno S; Boissier JR
    Biomedicine; 1973 Jul; 19(7):308-13. PubMed ID: 4783987
    [No Abstract]   [Full Text] [Related]  

  • 40. Anti-arrhythmic effect of nadolol in experimental arrhythmias: comparison with propranolol and alprenolol.
    Nakashima M; Takiguchi Y; Oguro K; Sogabe K; Hashimoto H
    J Pharmacobiodyn; 1985 Jan; 8(1):1-10. PubMed ID: 4009395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.